Cargando…
Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score
BACKGROUND: Treatment by immune checkpoint blockade (ICB) provides a remarkable survival benefit for multiple cancer types. However, disease aggravation occurs in a proportion of patients after the first couple of treatment cycles. METHODS: RNA sequencing data was retrospectively collected. 6 tumour...
Autores principales: | Liu, Si-Yang Maggie, Sun, Hao, Zhou, Jia-Ying, Zhang, Jia-Tao, Yin, Kai, Chen, Zhi-Hong, Su, Jian, Zhang, Xu-Chao, Yang, Jin-Ji, Zhou, Qing, Tu, Hai-Yan, Wu, Yi-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571398/ https://www.ncbi.nlm.nih.gov/pubmed/34715621 http://dx.doi.org/10.1016/j.tranon.2021.101254 |
Ejemplares similares
-
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
por: Xiong, Zhewen, et al.
Publicado: (2023) -
Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours
por: Bjellerup, P, et al.
Publicado: (2000) -
Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice
por: Yue, Wenwen, et al.
Publicado: (2019) -
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
por: Conche, Claire, et al.
Publicado: (2023) -
Unfavourable results in pollicisation
por: Thatte, Mukund R., et al.
Publicado: (2013)